Navigation Links
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
Date:8/17/2010

INDIANAPOLIS, Aug. 17 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary results from two ongoing long-term Phase III studies showed it did not slow disease progression and was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.

The company's decision does not affect the ongoing clinical trials of solanezumab, Lilly's other compound in Phase III trials as a potential Alzheimer's treatment. While both drugs focus on amyloid-beta proteins, which are believed to play a critical role in Alzheimer's disease, they have different mechanisms of action. Lilly also has two other compounds in earlier stages of clinical development; those studies are not affected by today's announcement.

In two pivotal Phase III trials, semagacestat was compared with placebo in more than 2,600 patients with mild-to-moderate Alzheimer's disease. Lilly has now reviewed data from a pre-planned interim analysis of semagacestat studies. This interim analysis showed that, as expected, cognition and the ability to complete activities of daily living of placebo-treated patients worsened.  However, by these same measures, patients treated with semagacestat worsened to a statistically significantly greater degree than those treated with placebo. In addition, data showed semagacestat is associated with an increased risk of skin cancer compared with those who received placebo.

"This is disappointing news for the millions of Alzheimer's patients and their families worldwide who anxiously await a successful treatment for this devastating illness," said Jan M. Lundberg, Ph.D., Executive Vice President, Science and Technology, and President, Lilly Research Laboratories. "This is a se
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)...  Boston Scientific has released the primary endpoint ... Failure (NECTAR-HF) clinical trial, the first and only ... (VNS) for the treatment of heart failure patients.  ... Cardiology and Director of the Clinical Investigation Center ... de la Recherche Medicale presented the results at ...
(Date:8/30/2014)... Aug. 30, 2014   Royal Philips  (NYSE: PHG, ... a new ultrasound system designed to enable global ... increasing patient volumes and cost pressures. Making its debut ... in Barcelona this week, Affiniti ... patients with fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research ... Industry, 2009-2019 is a professional and in-depth market ... Scanner industry . The report firstly reviews the ... classification, application and manufacturing technology. The report then ... Crystallography Scanner listing their product specification, capacity, Production ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
(Date:9/1/2014)... honor of National Take Your Cat to the Vet Day, which ... Minnesota (AERC) is offering a few reasons why pet owners should ... don’t take their cat to the vet because “there’s nothing wrong” ... not to take their kid to dentist because he or she ... Just like people want their loved ones to be healthy, they ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
(Date:9/1/2014)... 2014 Registration is now open for the ... 1-Mile Race to be held on Sunday, September 21, 2014. ... at Harmon Meadow in Secaucus, New Jersey. All proceeds from ... nonprofit dedicated to restoring a sense of self, restoring the ... our military families. , General registration is $30 with special ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... Las Vegas, NV (PRWEB) September 01, 2014 ... for entrepreneurs and online marketers that was developed to ... campaign, has caught the attention of Shane Michaels, prompting ... even established entrepreneur, the daily duty of managing all ... online business can be quite overwhelming,” reports Michaels. “That’s ...
Breaking Medicine News(10 mins):Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2
... -- The brains of people with autism concentrate more resources ... in areas used to plan and control thoughts and actions, ... people with autism have exceptional visual abilities, said the researchers ... 26 brain imaging studies that were conducted over 15 years ...
... Breast cancer risk can be assessed by examining ... preliminary study results presented at the AACR 102nd Annual ... method has the potential to provide a personalized assessment ... Arcaro, Ph.D., associate professor of veterinary and animal sciences ...
... Langone Medical Center have investigated a novel protein test ... accurately identify proteins secreted from cancerous tumors caused by ... Association for Cancer Research 102nd Annual Meeting 2011 on ... under the sponsorship of the National Cancer Institute,s Early ...
... , SUNDAY, April 3 (HealthDay News) -- New ... heart attack four years after the city was devastated ... Chronic stress, not being able to return home and ... situation, said the researchers, who updated their two-year post-Hurricane ...
... Health Study revealed that diabetes is associated with lower risk ... other cancers in both men and women. The data, to ... here April 2-6, also showed an association between diabetes and ... an association between diabetes and an increased risk for cancers ...
... SATURDAY, April 2 (HealthDay News) -- In a small preliminary ... number of episodes of a potentially dangerous irregular heartbeat known ... week also improved quality of life, lowering levels of the ... according to research to be presented Saturday at the annual ...
Cached Medicine News:Health News:Brains of People with Autism Focus More on Visual Skills 2Health News:Breast milk may provide a personalized screen of breast cancer risk 2Health News:New test detects early-stage, asbestos-related pulmonary cancer 2Health News:Heart Attack Risk Plagues Post-Katrina New Orleans 2Health News:Avoiding or controlling diabetes may reduce cancer risk and mortality 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 3
... The Laserex Tango ophthalmic laser system provides ... SLT laser and a photodisruptor for posterior ... a frequency-doubled Nd:YAG producing pulsed 532 nm ... producing 1064 nm. The appropriate laser can ...
Extremely thin and smooth jaws, jaws open to 5.5 mm, cross action....
Round handle....
5 mm concave jaws, cross action....
Medicine Products: